论文部分内容阅读
心房颤动是临床最常见的心律失常,发病随年龄增加而增加,对生命与健康构成威胁,转复窦性心律仍然是重要的选择,非药物治疗有手术、射频、电击除颤等治疗手段,但因为其操作有难度,易于复发以及并发症等原因,药物仍是心房颤动治疗的主线。一些新药可于近期投放临床用作心房颤动治疗,而还有一些药物正在试验当中。本文综述目前心房颤动药物治疗以及抗凝治疗最新进展,以对临床工作提供参考。
Atrial fibrillation is the most common clinical arrhythmia, the incidence increases with age, which poses a threat to life and health. The conversion of sinus rhythm is still an important choice. Non-drug treatment includes surgery, radiofrequency and electric shock defibrillation. However, because of its operation is difficult, easy to relapse and complications and other reasons, the drug is still the main line of treatment of atrial fibrillation. Some new drugs are available for clinical use as atrial fibrillation in the near future, while others are being tested. This article summarizes the current progress of atrial fibrillation drug therapy and anticoagulant therapy to provide reference for clinical work.